The Food and Drug Administration is announcing the first round of drugs that will receive drastically expedited reviews at ...

The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and ...

The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...

The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process ...

The U.S. Food and Drug Administration said on Friday that it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United ...

The US Food and Drug Administration on Thursday announced the first drug manufacturers that will receive expedited reviews as part of a new initiative to reward companies for acquiescing to the Trump ...

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative announced Tuesday. Food ...

The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for ...